Premium
Overexpression of cyclin D1 is rare in human prostate carcinoma
Author(s) -
Gumbiner Laura M.,
Gumerlock Paul H.,
Mack Philip C.,
Chi SungGil,
deVere White Ralph W.,
Mohler James L.,
Pretlow Thomas G.,
Tricoli James V.
Publication year - 1999
Publication title -
the prostate
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.295
H-Index - 123
eISSN - 1097-0045
pISSN - 0270-4137
DOI - 10.1002/(sici)1097-0045(19990101)38:1<40::aid-pros5>3.0.co;2-i
Subject(s) - cyclin d1 , prostate , du145 , cyclin d , cancer research , prostate cancer , cyclin , cyclin b , biology , pathology , medicine , cell cycle , cancer , lncap
BACKGROUND Overexpression of cyclin D1 has been documented in a number of human cancers. Increased expression of cyclin D1 can contribute to cellular transformation and abnormal proliferation. METHODS Quantitative RT‐PCR and/or Western blot analysis were used to determine the level of cyclin D1 expression in 96 human prostate tumors, 15 benign prostate hyperplasias, 4 prostate cancer cell lines, and 3 xenografts. RESULTS Our results demonstrate that 4.2% of the prostate tumors examined overexpressed cyclin D1 trasnscripts. In the cell lines, expression was normal, with the exception that reduced levels of cyclin D1 transcript and protein were observed in the DU145 cell line, as expected from cells with mutant RB. Normal levels of cyclin D1 were found in all xenograft tumors and BPH specimens examined. CONCLUSIONS These data show that overexpression of cyclin D1 occurs rarely in human prostate tumors. However, when overexpression of cyclin D1 does occur, it may identify a subset of tumors with a different molecular biology. Prostate 38:40–45, 1999. © 1999 Wiley‐Liss, Inc.